34d ago

Vitruvias Therapeutics recalls thyroid tablets over overdose risk

Vitruvias Therapeutics2026-08-26thyroid tablets

Vitruvias Therapeutics issued a recall on 26 August 2026 for thyroid tablets found to be "superpotent," warning that consumption could cause an overactive thyroid condition in users. The affected batches posed a health risk requiring immediate product withdrawal.

2 reports · 1 independentlocal

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage